The Bennett Distinguished Lecture 2023

DR. David Steensma

Clonal hematopoiesis: clinical implications and progress towards therapy

Dr. Steesma served as an Associate Professor at Harvard Medical School and has an extensive research record in myelodysplastic syndrome (MDS).
He is now the Global Head of Hematology for Novartis Institutes for BioMedical Research (NIBR).